Maria Llach Pou

Mrs. Maria Llach Pou

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 July 2021 in Molecular Psychiatry
Verified
Journal Article
Open access
PDF file
FWFrederike Winkel
Frederike Winkel
MRMaria Ryazantseva
Maria Ryazantseva
MVMathias B. Voigt
Mathias B. Voigt
GDGiuliano Didio
Giuliano Didio
ALAntonia Lilja
Antonia Lilja
ECEero Castren
Eero Castren
Elevated states of brain plasticity typical for critical periods of early postnatal life can be reinstated in the adult brain through interventions, such as antidepressant treatment and environmental enrichment, and induced plasticity may be critical for the antidepressant action. Parvalbumin-positive (PV) interneurons regulate the closure of developmental critical periods and can alternate between high and low plasticity states in response to experience in adulthood. We now show that PV plasticity states and cortical networks are regulated through the activation of TrkB neurotrophin receptors. Visual cortical plasticity induced by fluoxetine, a widely prescribed selective serotonin reuptake inhibitor (SSRI) antidepressant, was lost in mice with reduced expression of TrkB in PV interneurons. Conversely, optogenetic gain-of-function studies revealed that activation of an optically activatable TrkB (optoTrkB) specifically in PV interneurons switches adult cortical networks into a state of elevated plasticity within minutes by decreasing the intrinsic excitability of PV interneurons, recapitulating the effects of fluoxetine. TrkB activation shifted cortical networks towards a low PV configuration, promoting oscillatory synchrony, increased excitatory-inhibitory balance, and ocular dominance plasticity. OptoTrkB activation promotes the phosphorylation of Kv3.1 channels and reduces the expression of Kv3.2 mRNA providing a mechanism for the lower excitability. In addition, decreased expression and puncta of Synaptotagmin2 (Syt2), a presynaptic marker of PV interneurons involved in Ca2+-dependent neurotransmitter release, suggests lower inputs onto pyramidal neurons suppressing feed-forward inhibition. Together, the results provide mechanistic insights into how TrkB activation in PV interneurons orchestrates the activity of cortical networks and mediating antidepressant responses in the adult brain.

21 March 2023 in Neuropsychopharmacology
Verified
Journal Article
Open access
PDF file
EJElias Jetsonen
Elias Jetsonen
GDGiuliano Didio
Giuliano Didio
FWFrederike Winkel
Frederike Winkel
MPMaria Llach Pou
Maria Llach Pou
CBChloe Boj
Chloe Boj
JUJuzoh Umemori
Juzoh Umemori
Critical period-like plasticity (iPlasticity) can be reinstated in the adult brain by several interventions, including drugs and optogenetic modifications. We have demonstrated that a combination of iPlasticity with optimal training improves behaviors related to neuropsychiatric disorders. In this context, the activation of TrkB, a receptor for BDNF, in Parvalbumin-positive (PV+) interneurons has a pivotal role in cortical network changes. However, it is unknown if the activation of TrkB in PV+ interneurons is important for other plasticity-related behaviors, especially for learning and memory. Here, using mice with heterozygous conditional TrkB deletion in PV+ interneurons (PV-TrkB hCKO) in IntelliCage and fear erasure paradigms, we show that chronic treatment with fluoxetine, a widely prescribed antidepressant drug that is known to promote the activation of TrkB, enhances behavioral flexibility in spatial and fear memory, largely depending on the expression of the TrkB receptor in PV+ interneurons. In addition, hippocampal long-term potentiation was enhanced by chronic treatment with fluoxetine in wild-type mice, but not in PV-TrkB hCKO mice. Transcriptomic analysis of PV+ interneurons after fluoxetine treatment indicated intrinsic changes in synaptic formation and downregulation of enzymes involved in perineuronal net formation. Consistently, immunohistochemistry has shown that the fluoxetine treatment alters PV expression and reduces PNNs in PV+ interneurons, and here we show that TrkB expression in PV+ interneurons is required for these effects. Together, our results provide molecular and network mechanisms for the induction of critical period-like plasticity in adulthood.

28 April 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
FWFrederike Winkel
Frederike Winkel
MVMathias B. Voigt
Mathias B. Voigt
GDGiuliano Didio
Giuliano Didio
SMSalomé Matéo
Salomé Matéo
EJElias Jetsonen
Elias Jetsonen
ECEero Castren
Eero Castren
Activation state of Parvalbumin (PV) interneurons regulates neuronal plasticity, driving the closure of developmental critical periods and alternating between high and low plasticity states in response to experience in adulthood. We now show that PV plasticity states are regulated through the activation of TrkB neurotrophin receptors. Activation of an optically activatable TrkB (optoTrkB) specifically in PV interneurons switches adult cortical networks into a state of elevated plasticity within minutes by decreasing excitability of PV neurons. OptoTrkB activation induces changes in gene expression related to neuronal plasticity and excitability, and increases the phosphorylation of Kv3.1 channels. OptoTrkB activation shifted cortical networks towards a low PV configuration, promoting oscillatory synchrony and ocular dominance plasticity. Visual plasticity induced by fluoxetine was lost in mice lacking TrkB in PV neurons. Our data suggest a novel mechanism that dynamically regulates PV interneurons configuration state and orchestrates cortical networks during adulthood. Graphical

31 March 2023 in Cells
Verified
Journal Article
Open access
PDF file
MPMaria Llach Pou
Maria Llach Pou
CTCamille Thiberge
Camille Thiberge
MZMichiel Van der Zwan
Michiel Van der Zwan
AGAnnousha devi GOVINDAN
Annousha devi GOVINDAN
SPStéphanie Pons
Stéphanie Pons
ICIsabelle Cloëz-Tayarani
Isabelle Cloëz-Tayarani
The transplantation of neural progenitors into a host brain represents a useful tool to evaluate the involvement of cell-autonomous processes and host local cues in the regulation of neuronal differentiation during the development of the mammalian brain. Human brain development starts at the embryonic stages, in utero, with unique properties at its neotenic stages. We analyzed the engraftment and differentiation of human neuronal progenitor cells (hNPCs) transplanted in utero into the mouse brain. The influence of the environment was studied by transplanting human NPCs within the lateral ventricles (LV), compared with the prefrontal cortex (PFC) of immunocompetent mice. We developed a semi-automated method to accurately quantify the number of cell bodies and the distribution of neuronal projections among the different mouse brain structures, at 1 and 3 months post-transplantation (MPT). Our data show that human NPCs can differentiate between immature “juvenile” neurons and more mature pyramidal cells in a reproducible manner. Depending on the injection site, LV vs. PFC, specific fetal local environments could modify the synaptogenesis processes while maintaining human neoteny. The use of immunocompetent mice as host species allows us to investigate further neuropathological conditions making use of all of the engineered mouse models already available.

5 June 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
MPMaria Llach Pou
Maria Llach Pou
CTCamille Thiberge
Camille Thiberge
SPStéphanie Pons
Stéphanie Pons
UMUwe MASKOS
Uwe MASKOS
ICIsabelle Cloëz-Tayarani
Isabelle Cloëz-Tayarani
The α7 neuronal nicotinic receptor (α7-nAChR) gene, CHRNA7 , is widely expressed within the brain and at the periphery. It plays various important roles in cognition and immune functions. Decreased expression of α7-nAChR has been associated with Alzheimer’s disease (AD) triggered by the accumulation of the 42-amino acid beta-amyloid peptide (Aβ 1-42 ). The interactions of this peptide with α7-nAChR may represent a pivotal mechanism that is involved in pathogenesis of AD. The regulation of CHRNA7 is a complex process. Normal function of α7-nAChR in mammalian cells requires the co-expression of chaperone proteins such as RIC3 and NACHO which facilitate the formation of cell surface receptors. In humans, CHRNA7 regulation also involves the specific chimeric CHRFAM7A gene product dupα7, which may assemble with α7 subunits and lead to dominant negative regulation of α7-nAChR function. To further elucidate the complex interplay between CHRFAM7A gene product (dupα7), α7-nAChRs and Aβ 1-42 , we used human induced pluripotent stem cells (iPSC)-derived interneurons (INs). Four iPSC lines were analyzed for the presence of CHRFAM7A copies. Among them, a cell line with a null genotype was selected for the lentiviral overexpression of CHRFAM7A . Our data show that overexpression of CHRFAM7A led to a reduction in the surface detection of α7-nAChR ligand binding sites in iPSC-derived INs. INs expressing the α7-dupα7 subunit (α7-dupα7-INs) exhibited lower levels of RIC3 and NACHO. Upon agonist treatment by nicotine, an up-regulation of α7-nAChR ligand binding sites was observed in α7-dupα7-INs as compared to non-transduced INs (α7-INs). At low levels of Aβ treatment, α7-INs displayed a significant reduction in production of reactive oxygen species (ROS), while high levels resulted in a slight increase. In contrast, α7-dupα7-INs exhibited lower baseline levels of ROS that remained unaltered by Aβ treatment. ROS are known to exacerbate AD pathogenesis. We hypothesize that such effects may also be triggered by α7-dupα7-INs in the brain of patients. Further investigations are currently undertaken to confirm this hypothesis.

7 April 2026
Verified
Thesis
Closed access
MPMaria Llach Pou
Maria Llach Pou
Implication du gène CHRFAM7A dans la phase précoce de la maladie d'Alzheimer : études in vitro et développement d'un nouveau modèle de souris humanisée: CHRFAM7A est un gène spécifique à l'homme qui code pour la sous-unité dupα7 du récepteur nicotinique à l'acétylcholine (nAChR). Ce gène résulte d’une fusion entre une duplication partielle du gène CHRNA7 (codant pour la sous-unité α7) et du gène ULK4, il y a 200.000 ans. Le gène ancestral CHRNA7 a été associé à plusieurs troubles neurologiques dont la maladie d'Alzheimer (MA). En particulier, le récepteur α7-nAChR représente une cible directe pour le peptide amyloïde β (Aβ), l'une des principaux marqueurs moléculaires de la maladie, et facilite son accumulation intracellulaire toxique. Bien que des recherches approfondies aient été menées sur le rôle du α7-nAChR dans la MA, aucun essai clinique n'a permis d’obtenir des résultats satisfaisants. Ceci pourrait s’expliquer par une absence d’expression de la sous-unité dupα7 dans les modèles précliniques classiques. Il est important de noter que la sous-unité dupα7 peut s'incorporer aux pentamères α7-nAChR et réguler négativement leur fonction en réduisant le nombre de sites de liaison par rétention au sein du réticulum endoplasmique (RE). Dans le contexte de la MA, il a été montré que la sous-unité dupα7 réduit la capture de Aβ lorsqu’elle est exprimée dans des cultures neuronales et est associée à l'activation des réponses pro-inflammatoires induites par Aβ. Dans la première partie de la thèse, l’implication de la sous-unité humaine dans la toxicité induite par l'Aβ a été étudié in-vitro, à partir d’interneurones (INs) dérivés de cellules souches pluripotentes induites humaines (hiPSC). Avant la différenciation neuronale, les hiPSC portant 0 copie du gène ont été transduites avec une construction lentivirale CHRFAM7A. Pour évaluer la toxicité induite par l'Aβ, les niveaux de stress oxydatif des INs ont été évalués après exposition à différentes concentrations d'Aβ. Conformément au rôle protecteur de la sous-unité dupα7 décrit dans la littérature, les neurones exprimant cette sous-unité ont présenté un niveau de stress oxydatif de base plus faible. L'exposition à l'Aβ n'a pas modifié les niveaux d'expression de l'ARNm de CHRNA7 ou CHRFAM7A. Cependant, les INs exprimant la sous-unité dupα7 ont présenté une réduction significative des protéines chaperonnes NACHO et RIC3, indiquant l’existence possible d’un mécanisme de rétention du α7-nAChR dans le RE. Il est intéressant de noter qu'une courte exposition à la nicotine a induit une augmentation significative de l'expression membranaire du α7-nAChR dans les INs exprimant la sous-unité dupα7. In-vivo, les INs humains peuvent être xénogreffés et étudiés sur des périodes plus longues que lorsque maintenus en culture. Dans cette optique, une technique de transplantation de neurones dérivés d’hiPSC dans le cerveau de souris à des stades embryonnaires a été mise au point. Il a été démontré que les progéniteurs neuronaux humains transplantés in-utero intègrent et migrent vers différentes zones du cerveau. Dans ce modèle, nous montrons que l'environnement local au sein cerveau hôte influence significativement la maturation neuronale et la spinogénèse, à différents stades après la transplantation. Les résultats décrits dans cette thèse soulignent l'importance de considérer le CHRFAM7A spécifique à l'homme dans l'interaction complexe entre Aβ et α7-nAChR et ouvrent la voie au développement futur de thérapies ciblant α7-nAChR pour la maladie d'Alzheimer.